Diffuse large b-cell lymphoma arising in the lacrimal sac
- Authors
- Kim, J.; Kim, J.; Baek, S.
- Issue Date
- 2022
- Publisher
- Lippincott Williams and Wilkins
- Keywords
- Biopsy; Diffuse large B-cell lymphoma; Lacrimal sac; Ocular adnexal lymphoma
- Citation
- Journal of Craniofacial Surgery, v.33, no.1, pp.E19 - E21
- Indexed
- SCIE
SCOPUS
- Journal Title
- Journal of Craniofacial Surgery
- Volume
- 33
- Number
- 1
- Start Page
- E19
- End Page
- E21
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/146053
- DOI
- 10.1097/SCS.0000000000007861
- ISSN
- 1049-2275
- Abstract
- The authors report a single case of diffuse large B-cell lymphoma arising in the lacrimal sac. Diffuse large B-cell lymphoma is a third most common primary ocular adnexal lymphoma, which is the most common primary ocular malignant disease in adults. A patient came to our clinic with epiphora and a growing mass in the lacrimal sac. Enhanced computed tomography imaging suggested the presence of a malignant tumor and surgical excision and biopsy were performed. A final diagnosis of diffuse large B-cell lymphoma was reached by immunohistological and immunochemical staining. Two months after surgery, diffuse large B-cell lymphoma relapse occurred in the lacrimal sac and the patient underwent 6 cycles of chemotherapy. Diffuse large B-cell lymphoma is a curable disease when diagnosed early, and aggressive biopsy during surgery of the lacrimal sac is necessary to diagnose diffuse large B-cell lymphoma in the early stage. It is important to distinguish diffuse large B-cell lymphoma from other lacrimal system diseases. © 2022 Lippincott Williams and Wilkins. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholar.korea.ac.kr/handle/2021.sw.korea/146053)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.